Mannosylated Butyrophilin Tumour Markers
This invention relates to the finding that butyrophilins (BTNs) are mannosylated when expressed by cancer cells. Methods and compositions relating to the detection and treatment of cancer cells expressing mannosylated butyrophilins (BTNs) are provided.
Patents:WO 2,009,030,884
Inventor(s):
TROWSDALE JOHN [GB]; MALCHEREK GEORG [DE]
Type of Offer:
Sale
« More Medical Patents